ABSTRACT
Urgo Medical recently announced the launch of the Explorer study, a large, Europe-wide, clinical study on the efficacy and tolerability of UrgoStart Contact, a lipidocolloid technology dressing impregnated with nano-oligosaccharide factor, in the treatment of diabetic foot ulceration. The number of patients, investigating centres and countries involved, as well as the length of treatment and patient follow-up, make this an ambitious, double-blind, randomised controlled trial.
Subject(s)
Bandages, Hydrocolloid , Diabetic Foot/therapy , Randomized Controlled Trials as Topic , Adult , Carboxymethylcellulose Sodium , Europe , Humans , Multicenter Studies as Topic , Nanoparticles , Oligosaccharides , Research DesignABSTRACT
Despite advances in wound management in recent years, systemic wound infection remains the most common cause of death in patients with large trauma wounds; therefore, it is important that the wound is closed as soon as it is safe, not before and not too long after. However, all surgeons know that many acute trauma wounds cannot be safely closed on the day of injury, so how to judge when this critical window is open? In his inaugural lecture as Professor of Wound Study at Birmingham City University's Tissue Viability Practice Development Unit, Lt Col Professor Steven Jeffery addresses this issue.
Subject(s)
Wound Closure Techniques/trends , Wound Healing/physiology , Wound Infection/prevention & control , Wounds and Injuries/therapy , Humans , Time FactorsABSTRACT
The Tissue Viability Practice Development Unit at Birmingham City University aspires to be a centre of excellence, making a real difference to patients, and the carers and professionals looking after them. March 14 marked the inaugural lectures of Professors Michael Clark, Jackie Stephen-Haynes and David Gray, sponsored by the JWC. Their involvement in what the TVPDU is trying to achieve is a fantastic opportunity, both for the unit itself and for the field of tissue viability as a whole.
